Omeros (OMER) Equity Average (2011 - 2026)
Omeros' (OMER) quarterly Equity Average came in at -$92.3 million in Q1 2026, up 53.41% year-on-year from -$60.2 million in Q1 2025, and up 45.99% quarter-over-quarter from -$170.9 million in Q4 2025.
Omeros (OMER) Equity Average (2011 - 2026) Analysis & Trends
Omeros has disclosed Equity Average across 16 years of filings, most recently posting -$92.3 million for Q1 2026.
- Equity Average for Q1 2026 came in at -$92.3 million, up 53.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$92.3 million (up 53.41% YoY), and the FY2025 annual result was -$151.9 million, down 46.36% from the prior year.
- Equity Average came in at -$92.3 million for Q1 2026 at Omeros, up from -$170.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $70.3 million in Q1 2023 to a low of -$224.6 million in Q3 2025.
- The 5-year median for Equity Average is -$48.2 million (2024), against an average of -$76.4 million.
- Across the five-year window, Equity Average jumped 645.8% in 2023 and sank 4350.84% in 2024, its largest moves.
- Omeros' Equity Average stood at $19.7 million in 2022, then slumped by 198.9% to -$19.5 million in 2023, then sank by 764.98% to -$168.4 million in 2024, then dropped by 1.46% to -$170.9 million in 2025, then soared by 45.99% to -$92.3 million in 2026.
- The last three Equity Average figures came in at -$92.3 million (Q1 2026), -$170.9 million (Q4 2025), and -$224.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -92.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.28 Mn |
| Dec 31, 2025 | -170.85 Mn |
| Sep 30, 2025 | -224.58 Mn |
| Jun 30, 2025 | -221.12 Mn |
| Mar 31, 2025 | -198.08 Mn |
| Dec 31, 2024 | -168.39 Mn |
| Sep 30, 2024 | -139.39 Mn |
| Jun 30, 2024 | -97.96 Mn |
| Mar 31, 2024 | -48.16 Mn |
| Dec 31, 2023 | -19.47 Mn |
| Sep 30, 2023 | 3.28 Mn |
| Jun 30, 2023 | 37.72 Mn |
| Mar 31, 2023 | 70.31 Mn |
| Dec 31, 2022 | 19.69 Mn |
| Sep 30, 2022 | -39.51 Mn |
| Jun 30, 2022 | -18.81 Mn |
| Mar 31, 2022 | 9.43 Mn |
| Dec 31, 2021 | -119.46 Mn |
| Sep 30, 2021 | -254.50 Mn |
| Jun 30, 2021 | -234.13 Mn |